Gotowe bibliografie tematyczne / Vascular endothelial growth factor / Książki

Książki na temat „Vascular endothelial growth factor”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Vascular endothelial growth factor.
Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 20 lutego 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych książek naukowych na temat „Vascular endothelial growth factor”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

Woods, Stacy Ann. Signalling pathways regulating expression of vascular endothelial growth factor in human malignant astrocytomas. Ottawa: National Library of Canada, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Perlmutter, Robin Alexandra. Differential effects of platelet-derived growth factor isoforms on large and small vessel endothelial cells and vascular smooth muscle cells. [s.l: s.n.], 1992.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Liu, Bo. A study of the biological functions of vascular endothelial growth factor in tumour development. Birmingham: University of Birmingham, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Dunk, Caroline Elizabeth. The role of the vascular endothelial growth factor family in trophoblast and endothelial cell function: Relating to placental development. Birmingham: University of Birmingham, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

International Workshop "Novel Angiogenic Mechanisms" (2002 Columbus, Ohio). Novel angiogenic mechanisms: Role of circulating progenitor endothelial cells. New York: Kluwer Academic/Plenum, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

I, Moldovan Nicanor, red. Novel angiogenic mechanisms: Role of circulating progenitor endothelial cells. New York: Kluwer Academic/Plenum, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Bayko, Liisa Ann. The contribution of vascular endothelial growth factor induced angiogenesis to the progression of primary human melanoma. Ottawa: National Library of Canada = Bibliothèque nationale du Canada, 1999.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

service), ScienceDirect (Online, red. Tissue-specific vascular endothelial signals and vector targeting. Amsterdam: Elsevier, 2009.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Sisi, Paraskevi. Investigation of the role of vascular endothelial growth factor in the process of cervical ripening during parturition. Birmingham: University of Birmingham, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Fuchs, Johanna. Photodynamische - und anti - VEGF-Therapie als Kombinationstherapie bei der exsudativen altersabhängigen Makuladegeneration. Regensburg: Universitätsbibliothek Regensburg, 2017.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
11

Veillette, Christian J. H. Role of endothelin-1 in regulation of osteoblast differentiation and vascular endothelial growth factor-A in cell populations from fetal rat calvaria. Ottawa: National Library of Canada, 2002.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
12

Bandello, F. Anti-VEGF. Basel: Karger, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Anti-VEGF. Basel: Karger, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
14

Harmey, Judith H. VEGF and cancer. Georgetown, Tex: Landes Bioscience/Eurekah.com, 2004.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
15

Modeling tumor vasculature: Molecular, cellular, and tissue level aspects and implications. New York: Springer, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Kelleher, Siobhan. Signal transduction by endothelial cells: Investigation of early effects. Dublin: University College Dublin, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Sutton, Andrew Bryan. The response of endothelial cells and pericytes to transforming growth factor beta. Manchester: University of Manchester, 1993.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
18

Wang, David I. Kuo. The effects of fibroblast growth factor 2 on the early stages on in vitro endothelial wound repair. Ottawa: National Library of Canada, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

Arciniegas, Enrique A. The phenotype of vascular cells in culture: Regulation by transforming growth factor Beta-1. Manchester: University of Manchester, 1995.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Brozowski, Christine E. Effect of transforming growth factor-β1: Fibronectin and plasminogen activator inhibitor on migration of bovine aortic endothelial cells. [New Haven, Conn: s.n.], 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
21

International Symposium on Biotechnology of Growth Factors: Vascular and Nervous Systems (1991 Milan, Italy). Growth factors of the vascular and nervous systems: Functional characterization and biotechnology. Redaktorzy Albertini Alberto, Lenfant Claude i Paoletti Rodolfo. Basel: Karger, 1992.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
22

Huang, Kui. Vascular Endothelial Growth Factor Receptors in Angiogenesis. Uppsala Universitet, 2001.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

Parker, Marcellus L. Vascular Endothelial Growth Factor: Biology, Regulation and Clinical Significance. Nova Science Publishers, Incorporated, 2013.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
24

Claesson-Welsh, Lena. Vascular Growth Factors and Angiogenesis (Current Topics in Microbiology and Immunology). Springer-Verlag Telos, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
25

Ruhrberg, Christiana. VEGF in Development. Springer, 2009.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

Ruhrberg, Christiana. VEGF in Development. Springer London, Limited, 2008.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

Christiana, Ruhrberg, red. VEGF in development. Austin, Tex: Landes Bioscience/Eurekah.com, 2008.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

Rubanyi, Gabor M., i Werner Risau. Morphogenesis of Endothelium (Endothelial Cell Research Series). CRC, 2000.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
29

Michael, Simons, i Rubanyi Gabor M. 1947-, red. Modern concepts in angiogenesis. London: Imperial College Press, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Rubanyi, Gabor M., i Michael Simons. Modern Concepts in Angiogenesis. Imperial College Press, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

(Editor), Michael Simons, i Gabor M. Rubanyi (Editor), red. Modern Concepts in Angiogenesis. Imperial College Press, 2007.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

C, Weber Peter, i Leaf Alexander 1920-, red. Atherosclerosis: Cellular interactions, growth factors, and lipids. New York: Raven Press, 1993.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Weber, Peter C. Atherosclerosis: Cellular Interactions, Growth Factors, and Lipids (Atherosclerosis Reviews). Raven Pr, 1993.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
34

Remesal, Ana. Effects of Oxidative Stress and Antenatal Corticosteroids on the Pulmonary Expression of Vascular Endothelial Growth Factor (VEGF) and Alveolarization. INTECH Open Access Publisher, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

Maes, Christa. Angiogenesis & Bone: The Role Of The Vascular Endothelial Growth Factor Family In Bone Development And Repair (Acta Biomedica Lovaniensia). Leuven Univ Pr, 2004.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

Beverungen, Mirjam. Überprüfung der Wirkung von gefäßinduzierenden Wachstumsfaktoren (VEGF=Vascular Endothelial Growth Factor) auf die Vaskularisierung und Osteogenese in festen Knochenersatzstoffen. 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

Weber, Peter C. Atherosclerosis: Its Pathogenesis and the Role of Cholesterol (Atherosclerosis Reviews). Raven Pr, 1991.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

Processing Of Vegfc And Vegfd By The Pcs And Tumorigenesis. Biota Publishing, 2013.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

H, Harmey Judith, red. VEGF and cancer. Georgetown, Tex: Landes Bioscience/Eurekah.com ; New York, N.Y. : Kluwer Academic/Plenum Publishers, 2004.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
40

Harmey, Judith H. VEGF and Cancer. Springer, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

Harmey, Judith H. VEGF and Cancer. Springer, 2004.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
42

Cimpean, Anca Maria, Andreea Adriana Jitariu i Marius Raica. Growth Factors and Their Corresponding Receptors as Targets for Ovarian Cancer Therapy. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0011.

Pełny tekst źródła
Streszczenie:
Ovarian cancer remains one of the most aggressive and difficult to manage malignancies regarding evaluation and therapeutic options. The high mortality persists despite extensive research in the field. Current conventional chemotherapy does not improve disease-free survival and does not decrease recurrences amongst patients. This calls for a stringent reconsideration of the drugs selection, focused on the most targeted strategies and personalization of the therapy. Targeted agents against growth factors and their corresponding receptors are already approved as first- or second-line neoadjuvant therapy with controversial results. This chapter critically discusses the role of growth factors as vascular endothelial growth factor, fibroblast growth factors, or platelet-derived growth factors and their corresponding receptors in the pathogenesis, progression, and selection of therapeutic strategies. Other growth factors, such as nerve growth factor or endocrine gland derived growth factor, seem to have a strong involvement in ovarian carcinogenesis but their actual impact is not fully understood.
Style APA, Harvard, Vancouver, ISO itp.
43

The Textbook Of Angiogenesis And Lymphangiogenesis Methods And Applications. Springer, 2012.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Levi, Marcel, i Tom van der Poll. Coagulation and the endothelium in acute injury in the critically ill. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0307.

Pełny tekst źródła
Streszczenie:
Vascular endothelial cells play a pivotal mediatory role in many responses to systemic inflammation, including the cross-talk between coagulation and inflammation in sepsis. Endothelial cells respond to the cytokines expressed and released by activated leukocytes, but can also release cytokines themselves. Furthermore, endothelial cells are able to express adhesion molecules and growth factors that may not only promote the inflammatory response further, but also affect a myriad of downstream responses. It has recently become clear that, in addition to these mostly indirect effects of the endothelium, injured endothelial cells directly interfere with platelet-vessel wall interactions, neutrophil entrapment through formation of extracellular nets, and activation of inflammation and coagulation mediated by microparticles. The role of the glycocalyx as an important interface between the endothelium and regulation of coagulation in inflammatory states has also gained a lot of recent attention.
Style APA, Harvard, Vancouver, ISO itp.
45

G, Mikos Antonios, i Johnson Peter C, red. Angiogenesis. New Rochelle, NY: Mary Ann Liebert, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

Angiogenesis. New Rochelle, NY: Mary Ann Liebert, 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
47

G, Mikos Antonios, i Johnson Peter C, red. Advances in tissue engineering angiogenesis. New Rochelle, NY: Mary Ann Liebert, Inc., 2010.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

Eremina, Vera. Role of vascular endothelial growth factor A in the glomerulus: Analysis of phenotypes with glomerular-specific alterations of VEGF-A expression in murine transgenic lines. 2006.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
49

Woywodt, Alexander, i Diana Chiu. Drug-induced and toxic glomerulopathies. Redaktor Neil Turner. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0082.

Pełny tekst źródła
Streszczenie:
Glomerulopathies induced by particular exogenous compounds or molecules include those attributable to toxicity, and those caused by inducing an immune or autoimmune response. Tubules are more commonly the target of toxicity as they absorb and concentrate components of filtrate. Damage to endothelial cells may account for thrombotic microangiopathy in response to calcineurin inhibitors. Endothelial cells are also likely to be the target in drug-induced small vessel vasculitis. Toxicity to podocytes accounts for focal segmental glomerulosclerosis caused by pamidronate and other agents. Chloroquine can cause a remarkable pseudo-storage disorder with inclusions in podocytes that resemble those seen in Fabry disease. The mechanism by which drugs cause minimal change disease, another podocyte disorder, is not known. Membranous nephropathy may be caused by exposure to gold, mercury, and some other drugs; this is antibody mediated and presumably the targets are altered podocyte surface molecules. Inhibitors of the mammalian target of rapamycin (mTOR) cause proteinuria, possibly through effects on vascular endothelial growth factor, inhibitors of which are associated with not only proteinuria (an expected podocyte effect) but also thrombotic microangiopathy (endothelial cell effect). This latter may be through disturbing podocyte-endothelium cross-signaling.
Style APA, Harvard, Vancouver, ISO itp.
50

Maragoudakis, Michael E. Angiogenesis: Models, Modulators, and Clinical Applications. Springer, 2014.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany bibliografiami na temat „Vascular endothelial growth factor” dla innych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii